LIVING WITH CRC
Study identifies risk factors for irinotecan liver toxicityA retrospective study of 229 cancer patients receiving irinotecan chemotherapy identified key risk factors for hepatotoxicity, which could help clinicians monitor and manage this side effect more effectively. (Frontiers in Oncology)